Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 14, 2015; 21(2): 491-501
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.491
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.491
Figure 2 Overexpression of E2F-1 inhibits MGC-803 tumor growth.
A: Tumor growth curve shows the growth tendency in the LV-GFP-E2F-1 group is suppressed in comparison to the control groups; B: Relative tumor volume (TV) in LV-GFP-E2F-1-treated mice was significantly smaller than in the control groups at 12 d after tumor injection (n = 8 animals for each condition). 1, phosphate-buffered saline (PBS) control group; 2, LV-GFP-NC group; 3, LV-GFP-E2F-1 group; comparisons made using analysis of variance and Student-Newman-Keuls analyses; aP < 0.05 vs control.
-
Citation: Wei WY, Yan LH, Wang XT, Li L, Cao WL, Zhang XS, Zhan ZX, Yu H, Xie YB, Xiao Q. E2F-1 overexpression inhibits human gastric cancer MGC-803 cell growth
in vivo . World J Gastroenterol 2015; 21(2): 491-501 - URL: https://www.wjgnet.com/1007-9327/full/v21/i2/491.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i2.491